JOHN KIRKWOOD to Ligands
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Ligands.
Connection Strength
0.053
-
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype. Cancer Discov. 2015 Mar; 5(3):264-73.
Score: 0.027
-
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment. Melanoma Res. 2014 Jun; 24(3):207-18.
Score: 0.026